Colchicine could serve as treatment for outpatients of COVID-19: MHI


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Colchicine could serve as treatment for outpatients of COVID-19: MHI
COLCORONA is a non-contact, home, randomized, double-blind, placebo-controlled study conducted in Canada, the United States, Europe, South America, and South Africa

The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the control committee of independent data (DMC), following a second internal analysis.

"With the sharp increase in COVID-19 cases around the world, it is increasingly important that we continue to investigate treatments that not only help hospitalized patients with severe illness, but also those with milder symptoms and are in their homes ", highlighted Dr Jean-Claude Tardif , director of the Research Center at MHI, professor of Medicine at the University of Montreal , and COLCORONA chief researcher. "We want to complete patient enrollment in this large study in the next month and we hope that colchicine will reduce the risk of complications from COVID-19."

COLCORONA is a non-contact, home, randomized, double-blind, placebo-controlled study conducted in Canada, the United States, Europe, South America, and South Africa. It seeks to determine whether colchicine can reduce the risk of serious complications linked to COVID-19. This is one of the few current large-scale COVID-19 studies in which out-of-hospital patients can participate. 

COLCORONA is coordinated by the Montreal Health Innovations Coordination Center (MHICC) and is funded by the Government of Quebec , the Bill & Melinda Gates Foundation and the National Heart, Lung, and Blood Institute (NHLBI) of the United States National Institutes of Health (NIH). CGI, Dacima and Pharmascience are also COLCORONA collaborators.

The Montreal Cardiology Institute and its partners around the world would like to thank all the researchers and the thousands of participants for their continued participation in the COLCORONA study.

Tags : #MontrealHeartInstitute #LatestPharmaNews30thNov #LatestResearchonCOVIDTreatment30thNov #Canada #UnitedStates #BillMelindaGatesFoundation

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026